介质素-2 (IL-2) 多态度对多发性骨髓瘤的影响:IL-2RA rs2104286,IL-2 rs2069762和rs2069763多态度
Istemi Serin1, Yasin Colak1, Yasemin Oyaci2
1Department of Hematology, Agri Training and Research Hospital, Ibrahim Cecen University, Agri, Turkey.
Cytokine
|October 13, 2023
概括
干白素-2 (IL-2) 基因多态性并没有影响多发性骨髓瘤 (MM) 易感性. 然而,特定的IL-2基因型与MM患者较短的无进展生存期和整体生存期有关.
科学领域:
- 免疫遗传学 免疫遗传学
- 血液瘤学 血液瘤学
背景情况:
- 互乐金-2 (IL-2) 是一种关键的细胞因子,参与免疫反应.
- IL-2基因及其受体 (IL-2RA) 多态性与各种癌症有关.
- 在多发性骨髓瘤 (MM) 病原和预后中IL-2多态的作用需要进一步研究.
研究的目的:
- 调查IL-2RArs2104286,IL-2rs2069762和rs2069763多态性和多发性骨髓瘤 (MM) 易感性之间的关联.
- 评估这些多形态对MM无进展生存 (PFS) 和整体生存 (OS) 的影响.
主要方法:
- 在300名MM患者和170名健康对照中对IL-2RA rs2104286,IL-2 rs2069762和rs2069763进行基因型定型.
- 统计分析比较群体之间的基因型频率.
- 基因型与临床参数的相关性分析,包括PFS和OS.
主要成果:
- 在MM患者和健康对照人群之间没有观察到基因型频率的显著差异,这表明与MM易感性没有关联.
- 具有IL-2 rs2069762 TG基因型的患者表现出明显较短的中位数PFS和OS.
- 具有IL-2 rs2069763 GG基因型的患者显示PFS中位数显著较短.
结论:
- IL-2RA rs2104286,IL-2 rs2069762和rs2069763的多态性与多发性骨髓瘤易感性无关.
- 特定的IL-2基因多态 (rs2069762和rs2069763) 是MM患者减少PFS和OS的预后标记.
- 这些发现可能会为基于IL-2的治疗策略和MM的表观遗传学研究提供信息.
更多相关视频
10:21Author Spotlight: Exploring the Role of Inflammation in the Co-occurrence of Primary Sjogren's Syndrome and Lung Adenocarcinoma
Published on: September 20, 2024
482
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
33.8K
相关概念视频
01:24T Cell Types and Functions
1.0K
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
1.0K
01:05Single Nucleotide Polymorphisms-SNPs
15.2K
A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
15.2K